Record Revenues Achieved as Commercial Execution Continues; Management Reaffirms Fiscal 2016 Guidance SUNNYVALE, Calif. , Jan. 28, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2015 .
Achieves 8% year-over-year revenue growth; Generates $5.4 million of operating income SUNNYVALE, Calif. , April 26, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2016 .
SUNNYVALE, Calif. , Oct. 24, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017 . First Quarter Highlights Gross orders increased 11 percent to $55.6 million , net orders were $51.0 million .
New TomoTherapy Emerald Service Program Combines Best in Class Product Service Offerings with Guaranteed Uptime for Unparalleled Reliability and Customer Satisfaction SUNNYVALE, Calif., Sept. 6, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology
CyberKnife Radiosurgery Provides Patients an Effective, Non-Invasive and Convenient Treatment Option SUNNYVALE, Calif., April 2, 2012 – Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that Kuopio University Hospital in Kuopio, Finland has begun treating
The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin ( U.S. ), Tokyo, Japan and Tianjin, China Each facility offers a range of educational opportunities designed to advance patient care using the Accuray CyberKnife ® and Radixact ® Systems
Company Dedicates Local Resources to Expand Access to CyberKnife Radiosurgery for Country's Growing Aging Population SUNNYVALE, Calif., March 24, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the company has
Treatment Planning for the CyberKnife System and Other Radiation Therapy Devices Can Now be Performed Using the Same Software Solution SUNNYVALE, Calif. , June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.